CN115896347A - 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 - Google Patents
一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 Download PDFInfo
- Publication number
- CN115896347A CN115896347A CN202211248089.4A CN202211248089A CN115896347A CN 115896347 A CN115896347 A CN 115896347A CN 202211248089 A CN202211248089 A CN 202211248089A CN 115896347 A CN115896347 A CN 115896347A
- Authority
- CN
- China
- Prior art keywords
- influenza
- virus
- detecting
- primer
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000713196 Influenza B virus Species 0.000 title claims abstract description 76
- 241000712431 Influenza A virus Species 0.000 title claims abstract description 75
- 239000000523 sample Substances 0.000 title claims abstract description 72
- 241000700605 Viruses Species 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 150000007523 nucleic acids Chemical group 0.000 claims description 35
- 230000003321 amplification Effects 0.000 claims description 34
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 34
- 108020004707 nucleic acids Proteins 0.000 claims description 21
- 102000039446 nucleic acids Human genes 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 206010022000 influenza Diseases 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 208000037797 influenza A Diseases 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000013641 positive control Substances 0.000 claims description 9
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000013642 negative control Substances 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- 102000004420 Creatine Kinase Human genes 0.000 claims description 4
- 108010042126 Creatine kinase Proteins 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 4
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 4
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 3
- 102100034343 Integrase Human genes 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 2
- 101710116602 DNA-Binding protein G5P Proteins 0.000 claims description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108060004795 Methyltransferase Proteins 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 2
- 102000018120 Recombinases Human genes 0.000 claims description 2
- 108010091086 Recombinases Proteins 0.000 claims description 2
- 101710162453 Replication factor A Proteins 0.000 claims description 2
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 claims description 2
- 101710176276 SSB protein Proteins 0.000 claims description 2
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- -1 dNTP Chemical compound 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229950007002 phosphocreatine Drugs 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 24
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 238000011901 isothermal amplification Methods 0.000 abstract description 7
- 239000000443 aerosol Substances 0.000 abstract description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 208000037798 influenza B Diseases 0.000 description 8
- 241000712461 unidentified influenza virus Species 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 4
- 101150103639 PB1 gene Proteins 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 2
- 101900330348 Influenza A virus Matrix protein 1 Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 241000124740 Bocaparvovirus Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000726041 Human respirovirus 1 Species 0.000 description 1
- 241000712003 Human respirovirus 3 Species 0.000 description 1
- 241001559187 Human rubulavirus 2 Species 0.000 description 1
- 241001559186 Human rubulavirus 4 Species 0.000 description 1
- 241000713297 Influenza C virus Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 101150109178 M1 gene Proteins 0.000 description 1
- 241000351643 Metapneumovirus Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 241001514767 Respiratory syncytial virus type A Species 0.000 description 1
- 241000165108 Respiratory syncytial virus type B Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000027645 antigenic variation Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000011309 routine diagnosis Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/91—Cell lines ; Processes using cell lines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
试剂名称 | 加入体积(μL) |
甲型流感病毒上游引物(10μM) | 0.65 |
甲型流感病毒下游引物(10μM) | 0.65 |
甲型流感病毒探针(10μM) | 0.2 |
乙型流感病毒上游引物(10μM) | 0.65 |
乙型流感病毒下游引物(10μM) | 0.65 |
乙型流感病毒探针(10μM) | 0.2 |
酶混合液 | 4 |
缓冲液 | 10 |
激活剂 | 1 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211248089.4A CN115896347A (zh) | 2022-10-12 | 2022-10-12 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
PCT/CN2023/096010 WO2024077963A1 (zh) | 2022-10-12 | 2023-05-24 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211248089.4A CN115896347A (zh) | 2022-10-12 | 2022-10-12 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115896347A true CN115896347A (zh) | 2023-04-04 |
Family
ID=86471755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211248089.4A Pending CN115896347A (zh) | 2022-10-12 | 2022-10-12 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115896347A (zh) |
WO (1) | WO2024077963A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117004771A (zh) * | 2023-06-14 | 2023-11-07 | 南京迪飞医疗器械有限公司 | 一种呼吸道病毒多联检核酸快速检测方法及试剂盒 |
WO2024077963A1 (zh) * | 2022-10-12 | 2024-04-18 | 上海宝藤生物医药科技股份有限公司 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101652806B1 (ko) * | 2015-08-21 | 2016-09-01 | 주식회사 엠모니터 | Lamp를 이용한 인플루엔자 검출용 프라이머 및 그 용도 |
CN106555012A (zh) * | 2016-10-25 | 2017-04-05 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 用于a型动物流感病毒检测的试剂、检测方法及应用 |
CN109797245A (zh) * | 2019-02-21 | 2019-05-24 | 中国人民解放军东部战区总医院 | 一种用于检测乙型流感病毒的rpa引物、探针、试剂盒及应用 |
CN111534643B (zh) * | 2020-07-10 | 2020-10-09 | 上海科技大学 | 一种检测呼吸道病原的核酸的试剂盒、检测方法及应用 |
CN115896347A (zh) * | 2022-10-12 | 2023-04-04 | 上海宝藤生物医药科技股份有限公司 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
-
2022
- 2022-10-12 CN CN202211248089.4A patent/CN115896347A/zh active Pending
-
2023
- 2023-05-24 WO PCT/CN2023/096010 patent/WO2024077963A1/zh unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024077963A1 (zh) * | 2022-10-12 | 2024-04-18 | 上海宝藤生物医药科技股份有限公司 | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 |
CN117004771A (zh) * | 2023-06-14 | 2023-11-07 | 南京迪飞医疗器械有限公司 | 一种呼吸道病毒多联检核酸快速检测方法及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
WO2024077963A1 (zh) | 2024-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111020064B (zh) | 新型冠状病毒ORF1ab基因核酸检测试剂盒 | |
EP3882364B1 (en) | Dual detection kit for 2019 novel corona virus | |
CN111057797B (zh) | 新型冠状病毒2019-nCoV实时荧光定量PCR检测引物和探针、试剂盒和方法 | |
EP4116440A1 (en) | Rt-pcr detection method and kit for novel coronavirus | |
CN107365876B (zh) | 用于检测10项呼吸道感染病原体的试剂盒及其使用方法 | |
CN111187858A (zh) | 新型冠状病毒检测试剂盒 | |
CN115896347A (zh) | 一种用于检测甲型流感病毒和乙型流感病毒的引物探针组合及其应用 | |
WO2021155728A1 (zh) | 新型冠状病毒2019-nCoV核酸检测试剂盒 | |
CN112063756B (zh) | 多重检测呼吸道病毒核酸的方法及试剂盒 | |
CN111394513B (zh) | 新型冠状病毒SARS-CoV-2荧光定量PCR检测方法及其应用 | |
US20230193369A1 (en) | Composition, reaction liquid and method for improving qpcr test performance, and use thereof | |
CN112538550B (zh) | 基于RT-RPA和CRISPR/Cas的DHAV-1和DHAV-3检测体系及应用 | |
CN111334611B (zh) | 一种基于双扩增技术检测新型冠状病毒(2019-nCoV)的试剂盒及其应用 | |
CN110714098A (zh) | 一种用于检测猫杯状病毒和猫传染性腹膜炎病毒的组合物、试剂盒及其应用 | |
CN113930529B (zh) | 用于肺炎支原体检测的核酸片段、引物探针组、试剂盒及其应用 | |
CN111808995A (zh) | 一种呼吸道病原体核酸检测试剂盒 | |
CN110982940A (zh) | 基于熔解曲线的麻疹病毒、风疹病毒和腮腺炎病毒核酸检测的组合物及试剂盒 | |
CN105483289B (zh) | 一种肠道病毒三重直接荧光rt-pcr的检测试剂盒和反应体系 | |
CN112159868B (zh) | 一种新型冠状病毒荧光qRT-PCR法快速检测体系 | |
WO2023116064A1 (en) | Composition, kit and method for detection of sars-cov-2 and use thereof | |
CN114058742B (zh) | 一种引物探针组合物、包含其的试剂盒及其检测方法 | |
CN110724768A (zh) | 一种用于检测猫传染性腹膜炎病毒的组合物、试剂盒及方法 | |
LU500740B1 (en) | REAL-TIME FLUORESCENT PCR DETECTION PRIMERS AND PROBES, KIT AND METHOD FOR NOVEL CORONAVIRUS 2019-nCoV | |
CN113549709A (zh) | 利用巢式RPA技术检测SARS-CoV-2的引物对、探针、试剂盒及其应用 | |
CN114672594A (zh) | 一种检测肠道病毒71型的引物和探针组合及其试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230609 Address after: 201203 5th Floor, No. 3 Building, 180 Lane, Zhangheng Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai Applicant after: SHANGHAI BIOTECAN BIOLOGY MEDICINE TECHNOLOGY Co.,Ltd. Applicant after: Shanghai Huateng Biotechnology Co.,Ltd. Applicant after: SHANGHAI BIOTECAN MEDICAL DIAGNOSTICS Co.,Ltd. Address before: 201203 5th Floor, No. 3 Building, 180 Lane, Zhangheng Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai Applicant before: SHANGHAI BIOTECAN BIOLOGY MEDICINE TECHNOLOGY Co.,Ltd. Applicant before: Shanghai Huateng Biotechnology Co.,Ltd. Applicant before: SHANGHAI BIOTECAN MEDICAL DIAGNOSTICS Co.,Ltd. Applicant before: Shanghai Zhangjiang Medical Innovation Research Institute |
|
TA01 | Transfer of patent application right |